Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

BACKGROUND: In the Coronavirus Efficacy (COVE) trial, estimated mRNA-1273 vaccine efficacy against coronavirus disease-19 (COVID-19) was 94%. SARS-CoV-2 antibody measurements were assessed as correlates of COVID-19 risk and as correlates of protection. METHODS: Through case-cohort sampling, particip...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Peter B., Montefiori, David C., McDermott, Adrian, Fong, Youyi, Benkeser, David, Deng, Weiping, Zhou, Honghong, Houchens, Christopher R., Martins, Karen, Jayashankar, Lakshmi, Castellino, Flora, Flach, Britta, Lin, Bob C., O’Connell, Sarah, McDanal, Charlene, Eaton, Amanda, Sarzotti-Kelsoe, Marcella, Lu, Yiwen, Yu, Chenchen, Borate, Bhavesh, van der Laan, Lars W. P., Hejazi, Nima, Huynh, Chuong, Miller, Jacqueline, El Sahly, Hana M., Baden, Lindsey R., Baron, Mira, De La Cruz, Luis, Gay, Cynthia, Kalams, Spyros, Kelley, Colleen F., Kutner, Mark, Andrasik, Michele P., Kublin, James G., Corey, Lawrence, Neuzil, Kathleen M., Carpp, Lindsay N., Pajon, Rolando, Follmann, Dean, Donis, Ruben O., Koup, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366808/
https://www.ncbi.nlm.nih.gov/pubmed/34401888
http://dx.doi.org/10.1101/2021.08.09.21261290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366808/
https://www.ncbi.nlm.nih.gov/pubmed/34401888
http://dx.doi.org/10.1101/2021.08.09.21261290

Ejemplares similares